P. Deguiral

发表

EGFR Expression Is Unreliable to Decide for Cetuximab Treatment in Patients with Metastatic Colorectal Cancer: Results from “ERBITUX-OUEST”

J. Douillard, N. Padilla, J. Raoul, 2016 .

Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601.

J. Pignon, M. Ducreux, V. Boige, 2013, European journal of cancer.

Small Cell Carcinoma of the Esophagus: Analysis of 10 Cases and Review of the Published Data

J. Douillard, J. Bennouna, É. Bardet, 2000, American journal of clinical oncology.

Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients

F. Joly, J. Malhaire, E. Voog, 2020, International journal of cancer.

[A metastatic neuroendocrine tumor with exceptional outcome!].

C. Agard, P. Deguiral, M. F. Nomballais, 1998, La Revue de medecine interne.

Efficacy and safety of panitumumab in a cohort of patients with metastatic colorectal cancer in France: PANI OUEST, a post-EMA-approval descriptive study with a geriatric oncology focus.

J. Douillard, J. Metges, Z. Alavi, 2020, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

Adjuvant therapy in resectable gastric cancer.

H. Bleiberg, B. Gerard, P. Deguiral, 1992, British Journal of Cancer.

Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer

P. Laurent-Puig, C. Lepage, S. Coutant, 2022, Frontiers in Oncology.

5‐HTP induced diarrhea as a carcinoid syndrome model in mice?

M. Bourin, M. Hascoet, P. Deguiral, 1996, Fundamental & clinical pharmacology.

Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study

E. Blot, P. Ingrand, J. Douillard, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics

J. Douillard, P. Langlet, E. Jobard, 2014, Oncologie.

Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer: The FFCD PRODIGE 13 randomised phase III trial.

C. Lepage, O. Bouché, D. Pezet, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601.

J. Pignon, V. Boige, D. Malka, 2013, European journal of cancer.

Long Term Persistent Alopecia and Suboptimal Hair Regrowth after Adjuvant Chemotherapy for Breast Cancer: Alert for an Emerging Side Effect: ALOPERS Observatory.

F. Denis, P. Kerbrat, J. Metges, 2009 .